JP2014515356A5 - - Google Patents

Download PDF

Info

Publication number
JP2014515356A5
JP2014515356A5 JP2014511611A JP2014511611A JP2014515356A5 JP 2014515356 A5 JP2014515356 A5 JP 2014515356A5 JP 2014511611 A JP2014511611 A JP 2014511611A JP 2014511611 A JP2014511611 A JP 2014511611A JP 2014515356 A5 JP2014515356 A5 JP 2014515356A5
Authority
JP
Japan
Prior art keywords
composition
dry powder
value
vancomycin
max
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014511611A
Other languages
English (en)
Japanese (ja)
Other versions
JP6012716B2 (ja
JP2014515356A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/038775 external-priority patent/WO2012159103A1/en
Publication of JP2014515356A publication Critical patent/JP2014515356A/ja
Publication of JP2014515356A5 publication Critical patent/JP2014515356A5/ja
Application granted granted Critical
Publication of JP6012716B2 publication Critical patent/JP6012716B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014511611A 2011-05-19 2012-05-21 乾燥粉末バンコマイシン組成物および関連する方法 Expired - Fee Related JP6012716B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161487971P 2011-05-19 2011-05-19
US61/487,971 2011-05-19
PCT/US2012/038775 WO2012159103A1 (en) 2011-05-19 2012-05-21 Dry powder vancomycin compositions and associated methods

Publications (3)

Publication Number Publication Date
JP2014515356A JP2014515356A (ja) 2014-06-30
JP2014515356A5 true JP2014515356A5 (es) 2015-06-18
JP6012716B2 JP6012716B2 (ja) 2016-10-25

Family

ID=47177374

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014511611A Expired - Fee Related JP6012716B2 (ja) 2011-05-19 2012-05-21 乾燥粉末バンコマイシン組成物および関連する方法

Country Status (11)

Country Link
EP (1) EP2709646A4 (es)
JP (1) JP6012716B2 (es)
KR (1) KR101763195B1 (es)
CN (1) CN103717231B (es)
AU (1) AU2012254999B2 (es)
BR (1) BR112013029803B1 (es)
CA (2) CA2981038C (es)
IL (1) IL229506B (es)
MX (1) MX346244B (es)
SG (1) SG195038A1 (es)
WO (1) WO2012159103A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8226975B2 (en) 2005-12-08 2012-07-24 Insmed Incorporated Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
ES2743039T3 (es) * 2012-11-29 2020-02-18 Insmed Inc Formulaciones de vancomicina estabilizada
AU2014205483B2 (en) 2013-01-10 2017-11-30 Gilead Sciences, Inc. Non-selective kinase inhibitors
CN104043104B (zh) * 2013-03-15 2018-07-10 浙江创新生物有限公司 含盐酸万古霉素的喷雾干粉及其工业化制备方法
CN111743901B (zh) 2013-10-11 2023-09-12 普尔莫凯恩股份有限公司 喷雾干燥制剂
CN106029079A (zh) * 2014-02-28 2016-10-12 阿尔吉法玛公司 藻酸盐低聚物在治疗囊性纤维化和与缺陷性cftr离子通道功能相关的其它疾病中的应用
US10959946B2 (en) 2014-03-14 2021-03-30 Azurity Pharmaceuticals, Inc. Composition and method for vancomycin oral liquid
SI3142643T1 (sl) 2014-05-15 2019-11-29 Insmed Inc Postopki za zdravljenje pljučnih netuberkuloznih mikobakterijskih infekcij
SG11201703568WA (en) 2014-11-06 2017-05-30 Xellia Pharmaceuticals Aps Glycopeptide compositions
WO2016127087A1 (en) 2015-02-06 2016-08-11 Latitude Pharmaceuticals, Inc. Aqueous solution formulations of vancomycin
GB201609940D0 (en) * 2016-06-07 2016-07-20 Novabiotics Ltd Microparticles
KR102543227B1 (ko) 2016-10-27 2023-06-13 풀모킨 인코포레이티드 폐고혈압을 치료하기 위한 병용 요법
CN106963939A (zh) * 2017-03-22 2017-07-21 永信药品工业(昆山)股份有限公司 盐酸万古霉素药物组合物及其制备方法
CA3062570A1 (en) * 2017-05-22 2018-11-29 Insmed Incorporated Lipo-glycopeptide cleavable derivatives and uses thereof
US11571386B2 (en) 2018-03-30 2023-02-07 Insmed Incorporated Methods for continuous manufacture of liposomal drug products
WO2020081599A1 (en) * 2018-10-15 2020-04-23 Savara Inc. Separation of vancomycin and its degradation products

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR79615B (es) 1982-10-08 1984-10-31 Glaxo Group Ltd
US4778054A (en) 1982-10-08 1988-10-18 Glaxo Group Limited Pack for administering medicaments to patients
US4811731A (en) 1985-07-30 1989-03-14 Glaxo Group Limited Devices for administering medicaments to patients
JPH03193735A (ja) * 1989-12-22 1991-08-23 Shionogi & Co Ltd グリコペプチド系抗生物質の安定化組成物
JPH05963A (ja) 1990-04-13 1993-01-08 Toray Ind Inc ポリペプチド類組成物
US6582728B1 (en) 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
US6051256A (en) * 1994-03-07 2000-04-18 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
JP4142149B2 (ja) * 1997-07-10 2008-08-27 明治製菓株式会社 バンコマイシンの凍結乾燥製剤
US6586008B1 (en) * 1999-08-25 2003-07-01 Advanced Inhalation Research, Inc. Use of simple amino acids to form porous particles during spray drying
WO2001032144A1 (en) * 1999-10-29 2001-05-10 Inhale Therapeutic Systems, Inc. Dry powder compositions having improved dispersivity
DE60227691D1 (de) * 2001-11-01 2008-08-28 Nektar Therapeutics Sprühtrocknungsverfahren
DE10358387A1 (de) * 2003-12-13 2005-07-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulver enthaltend niedermolekulares Dextran und Verfahren zu deren Herstellung
FR2872044B1 (fr) * 2004-06-28 2007-06-29 Flamel Technologies Sa Formulation pharmaceutique a base d'antibiotique sous forme microcapsulaire
EP2050437A1 (en) * 2007-10-15 2009-04-22 Laboratoires SMB Improved pharmaceutical dry powder compositions for inhalation.
MX345158B (es) * 2008-10-07 2017-01-18 Raptor Pharmaceuticals Inc Formulaciones de fluoroquinolona en aerosol para farmacocinetica mejorada.
EP3184099A1 (en) * 2009-03-26 2017-06-28 Pulmatrix, Inc. Dry powder formulations and methods for treating pulmonary diseases
CA2754677A1 (en) * 2009-03-26 2010-09-30 Pulmatrix, Inc. Methods for treating and preventing pneumonia and ventilator-associated tracheobronchitis

Similar Documents

Publication Publication Date Title
JP2014515356A5 (es)
JP2016534153A5 (es)
JP2015509788A5 (es)
CA2836643C (en) Dry powder vancomycin compositions and associated methods
ES2823000T3 (es) Formulaciones muco-adhesivas de liberación controlada de levodopa y/o ésteres de levodopa y usos de las mismas
CN102008439B (zh) 一种姜黄素包覆脂质体制剂及其制备方法
JP2014501224A5 (es)
CA2653403C (en) Lipoic acid pellets
JP2013545748A5 (es)
JP2016523250A5 (es)
JP2016534142A5 (es)
JP2010537989A5 (es)
JP2009530415A5 (es)
JP2011502997A5 (es)
AU2012254999A1 (en) Dry powder vancomycin compositions and associated methods
JP2016500088A5 (es)
JP2015007131A5 (es)
RU2018144108A (ru) Никотиносодержащие частицы
EA031255B1 (ru) Состав с отсроченным высвобождением, содержащий гранулы цистеамина, и способы его получения и применения
JP2013505233A5 (es)
JP4465152B2 (ja) 味をマスキングした、顆粒及びコーティングされた顆粒剤
JP2013523676A5 (es)
WO2018072709A1 (zh) 医药微丸的干粉包衣组合物
JP2012509922A5 (es)
JP2011251959A5 (es)